Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 21.95 M23.44 M22.03 M24.8 M23.4 M 93.67 M Research & development 5.51 M5.29 M5.38 M5.05 M5.62 M 21.34 M Operating income -16.4 M-16.86 M-15.81 M-17.63 M-16.92 M -67.23 M Non-Operating Income, Total 1.98 M1.9 M1.85 M1.67 M1.53 M 6.96 M Interest expense, net of interest capitalized 3.56 M3.48 M3.48 M3.44 M3.37 M 13.76 M Non-Operating Income, excl. Interest Expenses -1.58 M-1.57 M-1.62 M-1.77 M-1.84 M -6.8 M Unusual income/expense ————— — Pretax income -25.67 M-18.44 M-17.43 M-19.4 M-18.76 M -74.03 M Equity in earnings ————— — Taxes 115 K104 K404 K95 K217 K 820 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -25.78 M-18.54 M-17.84 M-19.49 M-18.98 M -74.85 M Discontinued operations ————— — Net income -25.78 M-18.54 M-17.84 M-19.49 M-18.98 M -74.85 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -25.78 M-18.54 M-17.84 M-19.49 M-18.98 M -74.85 M Basic earnings per share (Basic EPS) -3.66-1.04-10.33-1.03 -2.74 Diluted earnings per share (Diluted EPS) -3.66-1.04-10.33-1.03 -2.74 Average basic shares outstanding 7 03817.74 K17.78 K15.21 K18.37 K — Diluted shares outstanding 7 03817.74 K17.78 K15.21 K18.37 K — EBITDA -15.3 M-17.14 M-13.83 M-19.61 M-15.72 M -66.3 M EBIT -16.6 M-18.29 M-14.84 M-20.49 M-16.52 M -70.14 M Cost of revenue 18.88 M20.98 M16.87 M19.51 M15.37 M 72.72 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1.29 M1.16 M1.01 M881 K795 K 3.84 M